.png){kind=logo}
NICE TO MEET YOU
We operate as an integrated and collaborative biotechnology platform, working with technology providers, research institutions, industry partners, and agricultural producers in alignment with the One Health framework.
Non-Antibiotic Bioactive Technologies
Advanced biotechnology platforms incorporating bacteriophage-based, peptide, and viral inhibitor technologies.
Manufacturing in Poland
Quality Assurance GMP
Collaborative research with academic institutions
21+ products in portfolio
Innova Biotechnology is incorporated in Poland.
We focus on the research, development, production, and commercialization of innovative non-antibiotic biotechnology solutions designed for integration into environmental, food processing, and agricultural systems in accordance with applicable regulatory frameworks.
We apply precision biology and microbial science to develop technologies intended for responsible system-level integration across animal production, environmental management, and related sectors.
We develop and manufacture bioactive and microbial technologies designed to support sustainable production practices across agriculture, livestock, aquaculture, and companion animal sectors, aligned with regulatory and safety standards.
Innova Biotechnology: Geo Presence
.png)
The United Nations Sustainable Development Goals (SDGs) provide a global framework for advancing sustainable development. They address key global challenges, including poverty, inequality, climate change, environmental sustainability, peace, and justice.
Nasze rozwiązania bezpośrednio przyczyniają się do:
OUR TEAM
Nipun Gupta
Managing Director (Strategy and Investor relationship)
Drawing upon over 20 years of experience, Nipun is responsible for implementing growth strategies. With a proven track record of success, he has spearheaded numerous commercial management operations and facilitated global commercial growth for biotechnology start-ups, VC-financed telecommunication projects, and Global IT & Telcos. His focus is always on achieving business objectives.
Dr. Paolo Doncecchi
Chief Technical Officer
Responsible for global sales and marketing. An energetic and resilient business manager with 35 years of experience in sales and marketing to deliver consistent P&L results in animal health (swine, poultry and cattle).
Paweł Kotula
Chief Operating and Finance Officer
With over 12 years of management experience, Paweł has served as a Board Member of Proteon Pharmaceuticals India and as Head of Business Planning & Analysis for a global telecommunications operator.
Tomasz Nowakowski
Business Development Director, Europe
Tomasz Nowakowski is a results-driven Sales Leader with over 20 years of experience spearheading B2B and B2C sales initiatives including biotechnology. Currently serving as Business Development Director, Europe at lnnova Biotechnology (Poland), he leads business growth in the animal biotechnology domain.
Pramod Kumar Singh
Country Manager - ISC & SEA I Senior Sales Leader I Biotechnology I B2B & B2C Strategy Expert
Accomplished and strategic Sales Leader with over 35 years of experience driving sustainable revenue growth and market leadership across the Indian Subcontinent (ISC) and Southeast Asia (SEA) regions. Proven expertise in leading cross-functional teams, executing high-impact sales strategies, and managing complex 82B and B2C operations within the biotechnology industry. Renowned for delivering consistent national and regional growth through innovative market expansion, strategic key account management, and customer-centric leadership. Adept at building long-term client relationships, navigating competitive landscapes, and exceeding performance benchmarks.
Ashish Narayan
Commercial Manager - Companion Animals
(Americas & Asia-Pacific)
Specializing in the international companion animal market, Ashish stands out for his commitment to advancing animal welfare and health. Expert in driving revenue growth through strategic innovation and customer-centric approaches across B2B and B2C segments. Skilled at building and maintaining relationships with key stakeholders including veterinarians, distributors, and pet owners worldwide to create meaningful value for pets, owners, and the global community through market insights and forward-thinking strategies.
Phillipe Demarck
Business Development Director
(LATAM and CIS)
Business Development Director for LATAM and CIS